Treatment of active psoriatic arthritis with the PPARγ ligand pioglitazone: An open-label pilot study

Tim Bongartz, B. Coras, T. Vogt, J. Schölmerich, U. Müller-Ladner

Research output: Contribution to journalArticlepeer-review

89 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of active psoriatic arthritis with the PPARγ ligand pioglitazone: An open-label pilot study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science